Journal profile · Genetics & Heredity
European Journal of Medical Genetics
ISSN 1769-7212 · eISSN 1878-0849 · Elsevier Masson SAS · NETHERLANDS · Quarterly · Founded 2005
European Journal of Medical Genetics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.14; hybrid open access; APC about USD 3,330; median 132 days to acceptance (101 articles, last 24 months); community-reported acceptance: easy; 71 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
European Journal of Medical Genetics is published by Elsevier Masson SAS and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Genomic variations and chromosomal abnormalities, Genetics and Neurodevelopmental Disorders and Genomics and Rare Diseases, together about 37.7% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
The European Journal of Medical Genetics (EJMG) is an Open Access journal and publishes articles on various aspects of human and medical genetics, the genetics of experimental models and developmental anomalies.The journal publishes topics including:Clinical genetics and genomics, including neurodevelopmental disorders (NDD), single or multiple malformations syndromes, and dysmorphology;Biology and pathophysiology of genetic and genomic diseases: biology of cell, pathways and systems, epigenetics and gene regulation, biology and pathophysiology of specific genes and non-coding DNA, and teratogenic factors;Rare inherited cancer predisposition syndromes;Fetal medicine, including prenatal diagnosis, prenatal screening, fetal therapies and teratology, and newborn screening;Diagnostic methods including sequencing studies (gene level), transcriptome studies, methylome and other Omics technologies, variant interpretation and functional validation, and bioinformatics and biostatistical methods in genetics;Personalized medicine and therapies, including gene therapy and gene editing, non-genetic treatment of genetic disease, pharmacogenetics and genomics, theragnostic and clinical trials;Formal genetics: Mendelian and non-Mendelian inheritance;Genetics and society: ethical aspects in genetics, impact of genomic medicine on public and patients, legal and reglementary aspects in genetics and clinical research, psychosocial aspects, rare diseases and genetics;Teaching and training in genetics;Genetic counseling;Please note: tumor genetics and studies focusing on multifactorial diseases are not in the scope of the Journal.EJMG is formerly known as Annales de Genetique.
From the journal's Aims & Scope
Research area (LetPub): Genetics & Heredity
Editor-in-chief Alain VerloesPublisher website
Editorial board by country: none in mainland China; most named United States 6, Spain 5, Belgium 4, Italy 3, United Kingdom 2 (53 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology17.6%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology10.5%
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology9.5%
- Congenital heart defects researchBiochemistry, Genetics and Molecular Biology7.3%
- Prenatal Screening and DiagnosticsMedicine6.5%
- Connective tissue disorders researchBiochemistry, Genetics and Molecular Biology4.3%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology4%
- Genetic Syndromes and ImprintingBiochemistry, Genetics and Molecular Biology4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.14LetPub ·
- Impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 4.3LetPub ·
- CiteScore (publisher)
- 4.3Publisher website ·
- SJR 2026-06
- 0.82LetPub ·
- SNIP 2026-06
- 1.05LetPub ·
- h-index
- 49LetPub ·
- h-index
- 86OpenAlex ·
- i10-index
- 1,642OpenAlex ·
- 2-year mean citedness
- 2.55OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 68.77%LetPub ·
Volume
- Articles per year
- 72LetPub ·
Articles by year OpenAlex count · 2,933 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 37 | 37 | 3 |
| 2025 | 71 | 71 | 95 |
| 2024 | 84 | 83 | 391 |
| 2023 | 143 | 82 | 927 |
| 2022 | 196 | 86 | 1,590 |
| 2021 | 205 | 62 | 2,193 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
132 daysMedian, submission to acceptance · P25–P75 97 days – 213 days
- Acceptance to online
- median 1 days (101 articles)
- Submission to online
- median 135 days
- Sample
- 101 articles with submission and acceptance dates (133 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 72 daysPublisher website ·
- Submission to acceptance
- 136 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,330 / EUR 3,120 / GBP 2,670 / JPY 413,020 | — | — | |
| Publisher website | USD 3,400 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Highlights
- Optional
- Not considered
- tumor genetics; studies focusing on multifactorial diseases
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Masson SAS
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Quarterly
- Founded
- 2005
- ISSN
- 1769-7212
- Electronic ISSN
- 1878-0849
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Journal of Medical Genetics
What CAS zone is European Journal of Medical Genetics in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Medical Genetics is in Zone 4 of Medicine, and in Zone 4 of the minor category Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Medical Genetics?
The latest impact factor listed by LetPub is 2.14; CiteScore 4.3, h-index 86.
How long does peer review take at European Journal of Medical Genetics?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 132 days (interquartile range 97–213 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of European Journal of Medical Genetics?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of European Journal of Medical Genetics based?
Of the 53 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (6), Spain (5) and Belgium (4). Counted from the institutions listed on the board page; for reference only.
Which databases index European Journal of Medical Genetics?
According to LetPub and DOAJ records, European Journal of Medical Genetics is indexed in SCIE and Scopus.
Is European Journal of Medical Genetics open access, and what is the APC?
European Journal of Medical Genetics is a hybrid journal. For open-access publication: APC about USD 3,330.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .